CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Bristol-Myers Squibb Co. v. AstraZeneca Pharmaceuticals LP

1:23-cv-00459

Overview

Case Number 1:23-cv-00459
Filing Date 2023-04-25
Status Terminated
Termination Date 2023-07-31
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

AstraZeneca Pharmaceuticals LP NPE (Individual / Inventor)

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

Bristol-Myers Squibb Co. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 13 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials 2 proceedings
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (13): πŸ‡―πŸ‡΅ Japan πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (2 found):
PTAB: 2
USPTO PTAB Trial 2016-06-29
IPR2016-01218

Merck Sharp & Dohme Corp. v. Ono Pharmaceutical Co., Ltd.

U.S. Continuation Sibling (9067999)
Status: Terminated-Settled
USPTO PTAB Trial 2016-06-29
IPR2016-01217

Merck Sharp & Dohme Corp. v. Ono Pharmaceutical Co., Ltd.

U.S. Continuation Sibling (9067999)
Status: Terminated-Settled
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US9402899
Immunopotentiative composition
Filed: 2014-04-04
Issued: 2016-08-02
Expired (Term Ended)
Expires: 2024-02-05

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

2

Dispositive

0

Granted

0

Denied

0

Pending / Review

2

Motions by Category

Procedural / Extension Motion 2

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
SO ORDERED, re 16 STIPULATION TO EXTEND TIME the Deadline for AstraZeneca Pharmaceuticals LP and AstraZeneca UK Ltd. to Answer, Move or Otherwise Respond to the...
Entry #19 • 2023-06-08 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME the Deadline for AstraZeneca Pharmaceuticals LP and AstraZeneca UK Ltd. to Answer, Move or Otherwise Respond to the Complaint to June...
Entry #16 • 2023-05-30 Document →

Docket Entries

(22 total)
Pleading / Complaint

COMPLAINT filed with Jury Demand against AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. (Filing fee $ 402, receipt number ADEDC-4121034) - filed by Tasuku Honjo, Bristol-Myers Squibb Co., Ono Pharmaceutical Co., Ltd., E. R. Squibb & Sons L.L.C., and Dana-Farber Cancer Institute, Inc. (Attachments: # 1 Exhibit 1, # 2 Civil Cover Sheet) (mkr) (Entered: 04/25/2023)

Entry #1 • 2023-04-25
1
Pleading / Complaint

COMPLAINT filed with Jury Demand against AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. (Filing fee $ 402, receipt number ADEDC-4121034) - filed by Tasuku Honjo, Bristol-Myers Squibb Co., Ono Pharmaceutical Co., Ltd., E. R. Squibb & Sons L.L.C., and Dana-Farber Cancer Institute, Inc. (Attachments: # 1 Exhibit 1, # 2 Civil Cover Sheet) (mkr) (Entered: 04/25/2023)

Entry #1 • 2023-04-25
2
Pleading / Complaint

COMPLAINT filed with Jury Demand against AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. (Filing fee $ 402, receipt number ADEDC-4121034) - filed by Tasuku Honjo, Bristol-Myers Squibb Co., Ono Pharmaceutical Co., Ltd., E. R. Squibb & Sons L.L.C., and Dana-Farber Cancer Institute, Inc. (Attachments: # 1 Exhibit 1, # 2 Civil Cover Sheet) (mkr) (Entered: 04/25/2023)

Entry #1 • 2023-04-25
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mkr) (Entered: 04/25/2023)

Entry #2 • 2023-04-25
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,402,899 B2. (mkr) (Entered: 04/25/2023)

Entry #3 • 2023-04-25
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc